Morgan Stanley’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Morgan Stanley's BSX.PRA Position: Q2 2023 in Review
Morgan Stanley sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 2,244 shares — an estimated $272K sold.
Morgan Stanley first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $5.77M in Q1 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.
- Morgan Stanley reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
- Morgan Stanley sold 2,244 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $272K.
- Morgan Stanley first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
- Morgan Stanley's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $5.77M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.
Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.